Press & News

We love what we do. A lot of other important folks love it too. See what they have to say about us.

Public Relations: Andrew Noble

Press Releases

September 20, 2022

DNAnexus Appoints Chief Commercial Officer to Accelerate Global Adoption of Leading Biomedical Data-Driven Technology Platform

MOUNTAIN VIEW, Calif. — DNAnexus, Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced the appointment of Stephen Nuckols as Chief Commercial Officer. The appointment follows the company’s recent $200 million financing round, which was led by Blackstone. Nuckols will be responsible for building on the company’s success, driving its commercial growth strategy, and leading its sales, solution science, and marketing functions.
Read More
September 12, 2022

DNAnexus Selected as Platform Provider of the Trusted Research Environment for UK’s Largest Health Research Program

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--DNAnexus, Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced that it has been awarded a three-year contract by Our Future Health. The DNAnexus platform, which will be hosted in the UK, will provide approved researchers with a scalable, cloud-based trusted research environment for accessing and analyzing Our Future Health’s growing biomedical dataset and tools to drive biological insights and global collaborations to advance precision medicine.
Read More
August 02, 2022

DNAnexus Named One of the 100 Best Workplaces for Innovators by Fast Company

MOUNTAIN VIEW, Calif. — Aug. 2, 2022 — DNAnexus, Inc., a leading provider of cloud-based biomedical data analysis software serving the life sciences community, today announced that it was included in Fast Company’s fourth annual Best Workplaces for Innovators list, honoring organizations and businesses that demonstrate a steadfast commitment to encouraging innovation at all levels.
Read More
July 13, 2022

DNAnexus and Twist Bioscience Collaborate to Provide Data Analysis Software for NGS Workflow

Collaboration integrates DNAnexus’ proven biomedical data analysis platform with Twist’s NGS Methylation Detection and Unique Molecular Identifier Adapter Systems
Read More
March 18, 2022

DNAnexus Secures $200 Million Funding Led by Blackstone Growth

Bioinformatics company DNAnexus Inc. has raised $200 million in a financing round led by Blackstone Inc. funds. The series I round values the Mountain View, California-based company at about $600 million, said people familiar with the matter who asked not to be identified discussing it.
Read More


Natera & DNAnexus: Scaling Genetic Testing Globally

Case Study New

TwinStrand Biosciences: Overcoming Bioinformacs Challenges to Rapidly Scale Genomics Pipelines

Dedicated to Detecting Ultra-Rare Variants with Unparalleled Sensitivity and Specificity
TwinStrand chose DNAnexus to provide the scalable and secure cloud infrastructure it needed to support customers of its DuplexSeq™ kits.

March 18, 2022

Blackstone Growth Leads $200 Million Investment in DNAnexus

One or two lines of text from article goes here mollis, mauris orci dignissim nisl, id gravida nunc enim quis nibh. Maecenas convallis eros a ante dignissim, vitae elementum metus facilisis. Cras in maximus sem. Praesent libero augue, ornare eget quam sed, volutpat suscipit arcu.
Read More
  • DNAnexus Solutions are used by......

  • 7 of the world’s top 10 pharmaceutical companies

  • 8 of the 10 biggest diagnostics developers

Collaboration is vital to advancing scientific discovery. We are excited to partner with Microsoft and DNAnexus to create infrastructure and tools to share data and accelerate progress toward finding cures for pediatric cancer and other life-threatening diseases.
James R. Downing, President & CEO
St. Judes Children’s Research Hospital